Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Ablating the mutant p53 gene in mice with colorectal cancer inhibits tumor growth

By genetically manipulating and removing the most common mutant form of the p53 gene that promotes colorectal cancer in humans, an international team of scientists demonstrated that this therapy reduces tumor growth and tissue invasion.

15 Aug 2018

Innovative program by community health centers increases colorectal cancer screening

An innovative program in community health centers to mail free colorectal cancer screening tests to patients' homes led to a nearly 4 percentage point increase in CRC screening, compared to clinics without the program, according to a Kaiser Permanente study published today in JAMA Internal Medicine.

10 Aug 2018

Researchers identify new regulator in breast cancer cells

Triple-negative breast cancer is a particularly aggressive form of breast cancer. Here, important receptors are missing, which often serve as targets for treatments.

6 Aug 2018

Researchers discover key piece for slowing colorectal cancer subtype

Inhibiting the Jagged 1 protein in mice prevents the proliferation and growth of colon and rectal tumors. What is more, this approach to the disease permits the removal of existing tumors.

2 Aug 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

CellMax Life receives six U.S. patents for early cancer detection blood test

CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.

24 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

New proteomics studies help gain more insights into Alzheimer's, cancer and listeriosis

The brains of people with Alzheimer's disease contain many protein aggregates outside of cells, known as plaques. These are mainly made of the peptide amyloid-beta, which is released from the plasma membrane when the protease BACE1 cleaves its membrane-anchored precursor protein.

19 Jul 2018

Weight loss surgery may impact individual's risk of developing cancer, shows study

A new analysis published in the BJS indicates that weight loss surgery may affect an individual's risk of developing cancer.

16 Jul 2018

Mailing colorectal cancer tests to patients increases screening rates, report researchers

Mailing colorectal cancer screening tests to patients insured by Medicaid increased screening rates for this population, report researchers at the University of North Carolina Comprehensive Cancer Center.

16 Jul 2018

Researchers uncover evolutionary history of IBD-associated bowel cancer

A team of researchers from Queen Mary University of London have reported the genetic events involved in the early development of bowel cancer in patients with inflammatory bowel disease.

11 Jul 2018

American Cancer Society outlines vision for cancer control in the decades ahead

The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that begins publishing today.

11 Jul 2018

Younger rectal cancer patients do not experience survival benefit from currently recommended therapies

A new study reveals that individuals younger than 50 years of age who are diagnosed with rectal cancer do not experience an overall survival benefit from currently recommended treatments.

9 Jul 2018

Study shows precision medicine improves outcomes in pancreatic cancer patients

A study published today by the Pancreatic Cancer Action Network, Perthera, Inc., and colleagues in the AACR journal Clinical Cancer Research found for the first time that precision medicine can improve outcomes and provide clinically meaningful information to pancreatic cancer patients.

28 Jun 2018

A small molecule can inhibit chemotherapy resistance of certain tumors

A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.

28 Jun 2018

New nuclear medicine approach shows potential for precision treatment of solid tumors

A novel nuclear medicine approach is showing great promise for precision treatment of solid tumors in many types of cancer--including lung, breast, pancreas and ovarian in adults and glioma, neuroblastoma and sarcoma in children.

26 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

WVU researchers increase colorectal cancer screening rates in West Virginia

In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.

21 Jun 2018

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Ablating the mutant p53 gene in mice with colorectal cancer inhibits tumor growth

Innovative program by community health centers increases colorectal cancer screening

Researchers identify new regulator in breast cancer cells

Researchers discover key piece for slowing colorectal cancer subtype

CNDA approves KEYTRUDA for treatment of advanced melanoma

CellMax Life receives six U.S. patents for early cancer detection blood test

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

New proteomics studies help gain more insights into Alzheimer's, cancer and listeriosis

Weight loss surgery may impact individual's risk of developing cancer, shows study

Mailing colorectal cancer tests to patients increases screening rates, report researchers

Researchers uncover evolutionary history of IBD-associated bowel cancer

American Cancer Society outlines vision for cancer control in the decades ahead

Younger rectal cancer patients do not experience survival benefit from currently recommended therapies

Study shows precision medicine improves outcomes in pancreatic cancer patients

A small molecule can inhibit chemotherapy resistance of certain tumors

New nuclear medicine approach shows potential for precision treatment of solid tumors

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

WVU researchers increase colorectal cancer screening rates in West Virginia

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in